MF Researcher Database

Researcher Database

Advance
KOIKE HIDEKAZU
Urology
Lecturer
Last Updated :2024/03/29

Researcher Profile and Settings

Researcher

  • Name

    KOIKE HIDEKAZU

Affiliation

  • Urology, Lecturer

Profile and Settings

  • Name

    HIDEKAZU, KOIKE

Affiliation

  • Gunma University, Lecturer

Affiliation

  • Affiliation

    University Hospital

  • Job title

    Lecturer

Research Experience

  • Gunma University

Research Activities

Published Papers

  • Initial Outcome of Robot-Assisted Radical Prostatectomy, Hidekazu Koike, Yoshitaka Sekine, Takeshi Miyao, Masashi Nomura, Hiroshi Matsui, Takahiro Syuutou, Sota Kurihara, Hiroshi Nakayama, Yoshiyuki Miyazawa , Yasuhiro Shibata, Kazuhiro Suzuki,, 70, 2, 83, 94
    DOI
  • YM155 Reverses Cabazitaxel Resistance in Castration-resistant Prostate Cancer by Reducing Survivin Expression, TAKESHI MIYAO, HIDEKAZU KOIKE, YOSHITAKA SEKINE, AKIRA OHTSU, DAISUKE OKA, KAZUHIRO SUZUKI
    DOI
  • Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3, SUZUKI KAZUHIRO / ITO KAZUTO / YAMAMOTO TAKUMI / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI / KOIKE HIDEKAZU / MATSUI HIROSHI / ONO YOSHIHIRO / HASUMI MASARU / NAKAZATO HARUKI / OKUGI HIRONOBU / SEKINE YOSHITAKA / OOKI KAZUNARI, Jun. 2002, Int J Cancer
  • Gene expression profiles in human BPH: utilization of laser-capture microdissection and quantitative real-time PCR, SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI / MATSUI HIROSHI / HASUMI MASARU / ONO YOSHIHIRO / NAKAZATO HARUKI / KOIKE HIDEKAZU / ITO KAZUTO / FUKABORI YOSHITATSU / KUROKAWA KOHEI, Nov. 2001, Anticancer Res
  • Placental growth factor gene expression in human prostate cancer and benign prostate hyperplasia, MATSUMOTO KAZUHISA / SUZUKI KAZUHIRO / KOIKE HIDEKAZU / HASUMI MASARU / MATSUI HIROSHI / OKUGI HIRONOBU / SHIBATA YASUHIRO / ITO KAZUTO / YAMANAKA HIDETOSHI, Sep. 2003, Anticancer Res
  • Association of genetic polymorphisms of Glutathione-S-transpherase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population, NAKAZATO HARUKI / ITO KAZUTO / KUROKAWA KOHEI / YAMANAKA HIDETOSHI / SUZUKI KAZUHIRO / MATSUI HIROSHI / KOIKE HIDEKAZU / OKUGI HIRONOBU / OHTAKE NOBUAKI / TAKEI TOMOYUKI / NAKATA SEIJI / HASUMI MASARU, May 2003, Anticancer Res
  • A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese, SUZUKI KAZUHIRO / ITO KAZUTO / KUROKAWA KOHEI / YAMANAKA HIDETOSHI / MATSUI HIROSHI / OHTAKE NOBUAKI / NAKATA SEIJI / TAKEI TOMOYUKI / NAKAZATO HARUKI / OKUGI HIRONOBU / KOIKE HIDEKAZU / ONO YOSHIHIRO, Jul. 2003, J Biomed Sci
  • Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate cancer risk in a Japanese population, SUZUKI KAZUHIRO / ITO KAZUTO / YAMANAKA HIDETOSHI / NAKAZATO HARUKI / MATSUI HIROSHI / KOIKE HIDEKAZU / OKUGI HIRONOBU / KASHIWAGI BUNZOU / NISHII MASAHIRO / OHTAKE NIBUAKI / NAKATA SEIJI, Oct. 2003, Cancer
  • Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues, HASUMI MASARU / SUZUKI KAZUHIRO / MATSUI HIROSHI / KOIKE HIDEKAZU / ITO KAZUTO / YAMANAKA HIDETOSHI, Oct. 2003, Cancer Lett
  • Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study, SUZUKI KAZUHIRO / HATORI MOTOAKI / ITO KAZUTO / YAMANAKA HIDETOSHI / MATSUI HIROSHI / NAKAZATO HARUKI / KOIKE HIDEKAZU / OKUGI HIRONOBU / HASUMI MASARU / OHTAKE NOBUAKI / NAKATA SEIJI / TAKEI TOMOYUKI, Jun. 2003, Cancer Lett
  • Association of the genetic polymorphism of the CYP19 intron 4 [TTTA]n repeat with familial prostate cancer risk in a Japanese population., SUZUKI KAZUHIRO / NAKAZATO HARUKI / MATSUI HIROSI / KOIKE HIDEKAZU / OKUGI HIRONOBU / OHTAKE NOBUAKI / NAKATA SEIJI / HASUMI MASARU / YAMANAKA HIDETOSHI, 2003, Anticancer Research
  • Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population, SUZUKI KAZUHIRO / ITO KAZUTO / OHTAKE NOBUAKI / NAKATA SEIJI / TAKEI TOMOYUKI / MATSUI HIROSHI / ONO YOSHIHIRO / NAKAZATO HARUKI / HASUMI MASARU / KOIKE HIDEKAZU, Nov. 2002, Anticancer Res
  • Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population., SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI / MATSUI HIROSHI / OHTAKE NOBUAKI / NAKATA SEIJI / TAKEI TOMOYUKI / KOIKE HIDEKAZU / NAKAZATO HARUKI / OKUGI HIRONOBU / HASUMI MASARU, May 2003, Int J Urol
  • Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer., KOIKE HIDEKAZU / ITO KAZUTO / OYAMA TETSUNARI / YAMANAKA HIDETOSHI / SUZUKI KAZUHIRO, Apr. 2005, Br J Cancer.
  • 集合管癌(Bellini管癌)の一例, 小池 秀和 / 武井智幸 / 大竹伸明 / 真下正道 / 鈴木 和浩 / 山中 英寿, Jul. 2002, 52,No.4(267-270)
  • 維持血液透析を施行した血友病Ａの１例, 小池 秀和, Jan. 2004, 37(1):91-94
  • 膀胱原発悪性リンパ腫の一例, 小池 秀和, May 2004, 95(4):675-678
  • 検診における胸部Ｘ線像から発見された前立腺癌, 小池 秀和, Aug. 2004, 58(9):695-698
  • 浸潤性膀胱癌に対する動注放射線療法, 小池 秀和, Jan. 2003, 57(1):43-46
  • Cyclin D1 gene polymorphism and familial prostate cancer : The AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage., KOIKE HIDEKAZU / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI / TAKEI TOMOYUKI / NAKATA SEIJI / SATHO T / OHTAKE NOBUAKI, Nov. 2003, Anticancer Research
  • 集合管癌（Bellini管癌）の一例, 小池 秀和, Jul. 2002, 52(4):267-270
  • Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population. , Koike H, Nakazato H, Ohtake N, Matsui H, Okugi H, Shibata Y, Nakata S, Yamanaka H, Suzuki K. , Mar. 2008, Int Urol Nephrol.
  • Gene Expression of Survivin and Its Spliced Isoforms Associated with Proliferation and Aggressive Phenotypes of Prostate Cancer. , Koike H, Sekine Y, Kamiya M, Nakazato H, Suzuki K., Mar. 2008, Urology
  • HER-2 gene polymorphism at codon 655 in familial prostate cancer in a Japanese population, Sekine Y, Hasumi M, Ohtake N, Nakata S, Nakazato H, Koike H and Suzuki K., 2005, Asia-Pacific Journal of Clinical Oncology
  • Methylation status of insulin-like growth factor-binding protein-3 promoter in prostate cancer tissues, Okugi H, Koike H, Sekine Y, Matsui H and Suzuki K, 2006, Asia-Pacific Journal of Clinical Oncology
  • Remnant lipoproteins stimulate proliferation and activete MARK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cells, Sekine Y, Koike H, Nakano T, Nakajima K and Suzuki K, 2007, Clinica Chemica Acta
  • High-Density Lipoprotein Induces Proliferation and Migration of Human Prostate Androgen-Independent Cancer Cells by an ABCA1-Dependent Mechanism., Sekine Y, Demosky SJ, Stonik JA, Furuya Y, Koike H, Suzuki K, Remaley AT., Aug. 2010, Molecular cancer research
  • Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer., Okamura K, Koike H, Sekine Y, Matsui H, Suzuki K., Aug. 2009, Cancer Epidemiology
  • 再燃抵抗性前立腺癌に対するドセタキセル療法の検討, 小池秀和、中里晴樹、新井誠二、森川泰如、関根芳岳、野村昌史、西井昌弘、曲　友弘、松井　 博、山本　巧、柴田康博、羽鳥基明、伊藤一人、鈴木和浩 , Aug. 2008, 21, 8, 1123~1126
  • Survivin is associated with cell proliferation and has a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer, 3.Koike H, Morikawa Y, Sekine Y, Matsui H, Shibata Y and Suzuki K., 2011, J Urol
  • Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation, 9.Morikawa Y, Koike H, Sekine Y, Matsui H, Shibata Y, Ito K and Suzuki K., 2012, Biochem Biophys Res Commun
  • Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer, Fukuma Y, Matsui H, Koike H, Sekine Y, Shechter I, Ohtake N, Nakata S, Ito K and Suzuki K. , 2012, Prostate Cancer and Prostatic Disease
  • Luteinizing horomone (LH)-releasing hormone agonist reduces serum adrenal androgen levels in prostate cancer patients: Implications for the effect of LH on the adrenal glands., 5.Nishii M, Nomura M, Sekine Y, Koike H, Matsui H, Shibata Y, Ito K, Oyama T and Suzuki K., 2012, J Androl.
  • Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related induces in men with total PSA in the 2.0-10.0ng/ml., Ito K, Miyakubo M, Sekine Y, Koike H, Matsui H, Shibata Y and Suzuki K., 2012
  • Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range, Ito, Kazuto; Miyakubo, Mai; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Suzuki, Kazuhiro, 2013, WORLD JOURNAL OF UROLOGY
    DOI
  • Simple method for preventing inguinal hernias after radical retropubic prostatectomy, Koike, Hidekazu; Matsui, Hiroshi; Morikawa, Yasuyuki; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2013, Prostate International
    DOI
  • Chlormadinone acetate is effective for hot flush during androgen deprivation therapy, Koike, Hidekazu; Morikawa, Yasuyuki; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2013, Prostate International
    DOI
  • Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer, Matsuyama, Hideyasu; Shimabukuro, Tomoyuki; Hara, Isao; Kohjimoto, Yasuo; Suzuki, Kazuhiro; Koike, Hidekazu; Uemura, Hirotsugu; Hayashi, Taiji; Ueno, Munehisa; Kodaira, Kiichiro; Tomita, Yoshihiko; Sakurai, Toshihiko; Shimizu, Nobuaki, Oct. 2014, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
    DOI
  • YM155 reverses rapamycin resistance in renal cancer by decreasing survivin, Koike, Hidekazu; Nitta, Takashi; Sekine, Yoshitaka; Arai, Seiji; Furuya, Yosuke; Nomura, Masashi; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Oyama, Tetsunari; Suzuki, Kazuhiro, Oct. 2014, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    DOI
  • Suicide attempt with an overdose of sunitinib, Arai, Seiji; Matsui, Hiroshi; Ohki, Ryo; Miyazawa, Yoshiyuki; Koike, Hidekazu; Hashita, Tadahiro; Katsuyama, Yoshihiko; Sekine, Yoshitaka; Nomura, Masashi; Shibata, Yasuhiro; Hatori, Motoaki; Ito, Kazuto; Yamamoto, Koujirou; Ohmori, Shigeru; Suzuki, Kazuhiro, Oct. 2014, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    DOI
  • Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor, Kato, Haruo; Sekine, Yoshitaka; Furuya, Yosuke; Miyazawa, Yoshiyuki; Koike, Hidekazu; Suzuki, Kazuhiro, 2015, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    DOI
  • A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer, Suzuki, Kazuhiro; Ozono, Seiichiro; Yamaguchi, Akito; Koike, Hidekazu; Matsui, Hiroshi; Nagata, Masao; Takubo, Takatoshi; Miyashita, Kana; Matsushima, Takafumi; Akaza, Hideyuki, 2015, CANCER CHEMOTHERAPY AND PHARMACOLOGY
    DOI
  • 精索静脈瘤に対する術中インドシアニングリーン蛍光血管造影下顕微鏡下低位結紮術の有用性：予備的検討, 柴田 康博,栗原 聰太,新井 誠二,宮澤 慶行,加藤 春雄,小池 秀和,伊藤 一人,中村 哲也,鈴木 和浩 , 2015, 106, 4, 293-298
  • 総排泄腔外反症に有棘細胞癌を合併した一例, 大津 晃,宮尾 武士,小池 秀和,馬場 恭子,青木 雅典,栗原 聰太,宮澤 慶行,加藤 春雄,周東 孝浩,新井 誠二,古谷 洋介,新田 貴士,野村 昌史,関根 芳岳,松井 博,柴田 康博,伊藤 一人,鈴木 和浩,牧口 貴哉,森田 廣樹,古作 望,松本 和久,富田 光,山本 巧,林 雅道 , 2015, 106, 4, 274-279
  • Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate Cancer, Kato, Haruo; Furuya, Yosuke; Miyazawa, Yoshiyuki; Miyao, Takeshi; Syuto, Takahiro; Nomura, Masashi; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, Nov. 2016, ANTICANCER RESEARCH
    DOI
  • 家族性前立腺癌の遺伝子解析と臨床応用の可能性, 松井 博,大竹 伸明,中田 誠司,栗原 聰太,小池 秀和,鈴木 和浩 , 2016, 3, 1, 53-60
  • Growing teratoma syndromeの1例, 馬場 恭子,関根 芳岳,栗原 聰太,小池 秀和,松井 博,中里 晴樹,柴田 康博,伊藤 一人,鈴木 和浩,西井 昌弘,真下 透,岡村 桂吾,平戸 純子 , 2016, 107, 2, 115-120
  • A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Syuto, Takahiro; Nomura, Masashi; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2017, BMC UROLOGY
    DOI
  • Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL, Fujizuka, Yuji; Ito, Kazuto; Oki, Ryo; Suzuki, Rie; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Suzuki, Kazuhiro, 2017, INTERNATIONAL JOURNAL OF UROLOGY
    DOI
  • Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Syuto, Takahiro; Nomura, Masashi; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2017, ANTICANCER RESEARCH
    DOI
  • Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content, Shibata, Yasuhiro; Arai, Seiji; Miyazawa, Yoshiyuki; Shuto, Takahiro; Nomura, Masashi; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Ito, Kazuto; Suzuki, Kazuhiro, 2017, PROSTATE
    DOI
  • Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Kato, Haruo; Furuya, Yosuke; Koike, Hidekazu; Suzuki, Kazuhiro, 2017, PROSTATE
    DOI
  • Efficacy of Indocyanine Green Angiography on Microsurgical Subinguinal Varicocelectomy, Shibata, Yasuhiro; Kurihara, Sota; Arai, Seiji; Kato, Haruo; Suzuki, Tomomi; Miyazawa, Yoshiyuki; Koike, Hidekazu; Ito, Kazuto; Nakamura, Tetsuya; Suzuki, Kazuhiro, 2017, JOURNAL OF INVESTIGATIVE SURGERY
    DOI
  • YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin, Nitta, Takashi; Koike, Hidekazu; Miyao, Takeshi; Miyazawa, Yoshiyuki; Kato, Haruo; Furuya, Yosuke; Sekine, Yoshitaka; Suzuki, Kazuhiro, 2017, ANTICANCER RESEARCH
    DOI
  • 去勢抵抗性前立腺癌に対するカバジタキセル療法の治療経験 , 宮尾 武士,小池 秀和,栗原 聡太,中山 紘史,大木 亮,宮澤 慶行,周東 孝浩,関根 芳岳,野村 昌史,松井 博,柴田 康博,伊藤 一人,鈴木 和浩 , Oct. 2017, 4, 2, 293-297
  • Effect of Androgen-deprivation Therapy on Bone Mineral Density in Japanese Patients with Prostate Cancer, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Syuto, Takahiro; Nomura, Masashi; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2018, IN VIVO
    DOI
  • 前立腺局所所見に乏しく急速に進行した転移性前立腺癌の1 例, 金山あずさ,宮尾武士,小池秀和,澤田達宏,馬場恭子,鈴木智美,栗原聰太,中山紘史,大木亮,宮澤慶行,藤塚雄司,周東孝浩,宮久保真意,野村昌史,関根芳岳,松井博,柴田康博,伊藤一人,鈴木和浩,平戸純子,猿木和久, 2018, 5, 1, 147-150

MISC

  • Gene Expression of Survivin and Its Spliced Isoforms Associated With Proliferation and Aggressive Phenotypes of Prostate Cancer, Hidekazu Koike,Yoshitaka Sekine,Makoto Kamiya,Haruki Nakazato,Kazuhiro Suzuki, Dec. 2008, UROLOGY, 72, 6, 1229, 1233
    DOI
  • Gene Expression of Survivin and Its Spliced Isoforms Associated With Proliferation and Aggressive Phenotypes of Prostate Cancer, Hidekazu Koike,Yoshitaka Sekine,Makoto Kamiya,Haruki Nakazato,Kazuhiro Suzuki, Dec. 2008, UROLOGY, 72, 6, 1229, 1233
    DOI
  • Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population, Hidekazu Koike,Haruki Nakazato,Nobuaki Ohtake,Hiroshi Matsui,Hironobu Okugi,Yasuhiro Shibata,Seiji Nakata,Hidetoshi Yamanaka,Kazuhiro Suzuki, Dec. 2008, INTERNATIONAL UROLOGY AND NEPHROLOGY, 40, 4, 947, 951
    DOI
  • Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population, Hidekazu Koike,Haruki Nakazato,Nobuaki Ohtake,Hiroshi Matsui,Hironobu Okugi,Yasuhiro Shibata,Seiji Nakata,Hidetoshi Yamanaka,Kazuhiro Suzuki, Dec. 2008, INTERNATIONAL UROLOGY AND NEPHROLOGY, 40, 4, 947, 951
    DOI
  • Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor, Haruo Kato,Yoshitaka Sekine,Yosuke Furuya,Yoshiyuki Miyazawa,Hidekazu Koike,Kazuhiro Suzuki, May 2015, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 461, 1, 115, 121
    DOI
  • A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer, Kazuhiro Suzuki,Seiichiro Ozono,Akito Yamaguchi,Hidekazu Koike,Hiroshi Matsui,Masao Nagata,Takatoshi Takubo,Kana Miyashita,Takafumi Matsushima,Hideyuki Akaza, Feb. 2015, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 75, 2, 373, 380
    DOI
  • A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer, Kazuhiro Suzuki,Seiichiro Ozono,Akito Yamaguchi,Hidekazu Koike,Hiroshi Matsui,Masao Nagata,Takatoshi Takubo,Kana Miyashita,Takafumi Matsushima,Hideyuki Akaza, Feb. 2015, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 75, 2, 373, 380
    DOI
  • Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer, Keigo Okamura,Hidekazu Koike,Yoshitaka Sekine,Hiroshi Matsui,Kazuhiro Suzuki, Aug. 2009, CANCER EPIDEMIOLOGY, 33, 2, 137, 141
    DOI
  • Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer, Keigo Okamura,Hidekazu Koike,Yoshitaka Sekine,Hiroshi Matsui,Kazuhiro Suzuki, Aug. 2009, CANCER EPIDEMIOLOGY, 33, 2, 137, 141
    DOI
  • Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range, Kazuto Ito,Mai Miyakubo,Yoshitaka Sekine,Hidekazu Koike,Hiroshi Matsui,Yasuhiro Shibata,Kazuhiro Suzuki, Apr. 2013, WORLD JOURNAL OF UROLOGY, 31, 2, 305, 311
    DOI
  • High-Density Lipoprotein Induces Proliferation and Migration of Human Prostate Androgen-Independent Cancer Cells by an ABCA1-Dependent Mechanism, Yoshitaka Sekine,Steve J. Demosky,John A. Stonik,Yosuke Furuya,Hidekazu Koike,Kazuhiro Suzuki,Alan T. Remaley, Sep. 2010, MOLECULAR CANCER RESEARCH, 8, 9, 1284, 1294
    DOI
  • High-Density Lipoprotein Induces Proliferation and Migration of Human Prostate Androgen-Independent Cancer Cells by an ABCA1-Dependent Mechanism, Yoshitaka Sekine,Steve J. Demosky,John A. Stonik,Yosuke Furuya,Hidekazu Koike,Kazuhiro Suzuki,Alan T. Remaley, Sep. 2010, MOLECULAR CANCER RESEARCH, 8, 9, 1284, 1294
    DOI
  • Remnant lipoproteins stimulate proliferation and activate MAPK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cells, Yoshitaka Sekine,Hidekazu Koike,Takamitsu Nakano,Katsuyuki Nakajima,Kazuhiro Suzuki, Aug. 2007, CLINICA CHIMICA ACTA, 383, 1-2, 78, 84
    DOI
  • Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer, H Koike,K Ito,Y Takezawa,T Oyama,H Yamanaka,K Suzuki, Apr. 2005, BRITISH JOURNAL OF CANCER, 92, 8, 1538, 1544
    DOI
  • Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer, H Koike,K Ito,Y Takezawa,T Oyama,H Yamanaka,K Suzuki, Apr. 2005, BRITISH JOURNAL OF CANCER, 92, 8, 1538, 1544
    DOI
  • Luteinizing Hormone (LH)-Releasing Hormone Agonist Reduces Serum Adrenal Androgen Levels in Prostate Cancer Patients: Implications for the Effect of LH on the Adrenal Glands, Masahiro Nishii,Masashi Nomura,Yoshitaka Sekine,Hidekazu Koike,Hiroshi Matsui,Yasuhiro Shibata,Kazuto Ito,Tetsunari Oyama,Kazuhiro Suzuki, Nov. 2012, JOURNAL OF ANDROLOGY, 33, 6, 1233, 1238
    DOI
  • Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer, Y. Fukuma,H. Matsui,H. Koike,Y. Sekine,I. Shechter,N. Ohtake,S. Nakata,K. Ito,K. Suzuki, Dec. 2012, PROSTATE CANCER AND PROSTATIC DISEASES, 15, 4, 339, 345
    DOI
  • Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer, Y. Fukuma,H. Matsui,H. Koike,Y. Sekine,I. Shechter,N. Ohtake,S. Nakata,K. Ito,K. Suzuki, Dec. 2012, PROSTATE CANCER AND PROSTATIC DISEASES, 15, 4, 339, 345
    DOI
  • Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation, Yasuyuki Morikawa,Hidekazu Koike,Yoshitaka Sekine,Hiroshi Matsui,Yasuhiro Shibata,Kazuto Ito,Kazuhiro Suzuki, Mar. 2012, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 419, 3, 584, 589
    DOI
  • Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation, Yasuyuki Morikawa,Hidekazu Koike,Yoshitaka Sekine,Hiroshi Matsui,Yasuhiro Shibata,Kazuto Ito,Kazuhiro Suzuki, Mar. 2012, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 419, 3, 584, 589
    DOI
  • Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3, K Suzuki,H Koike,H Matsui,Y Ono,M Hasumi,H Nakazato,H Okugi,Y Sekine,K Oki,K Ito,T Yamamoto,Y Fukabori,K Kurokawa,H Yamanaka, Jun. 2002, INTERNATIONAL JOURNAL OF CANCER, 99, 6, 846, 852
    DOI
  • Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3, K Suzuki,H Koike,H Matsui,Y Ono,M Hasumi,H Nakazato,H Okugi,Y Sekine,K Oki,K Ito,T Yamamoto,Y Fukabori,K Kurokawa,H Yamanaka, Jun. 2002, INTERNATIONAL JOURNAL OF CANCER, 99, 6, 846, 852
    DOI
  • Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues, M Hasumi,K Suzuki,H Matsui,H Koike,K Ito,H Yamanaka, Oct. 2003, CANCER LETTERS, 200, 2, 187, 195
    DOI
  • Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues, M Hasumi,K Suzuki,H Matsui,H Koike,K Ito,H Yamanaka, Oct. 2003, CANCER LETTERS, 200, 2, 187, 195
    DOI
  • Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study, K Suzuki,H Matsui,H Nakazato,H Koike,H Okugi,M Hasumi,N Ohtake,S Nakata,T Takei,M Hatori,K Ito,H Yamanaka, Jun. 2003, CANCER LETTERS, 195, 2, 177, 183
    DOI
  • Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study, K Suzuki,H Matsui,H Nakazato,H Koike,H Okugi,M Hasumi,N Ohtake,S Nakata,T Takei,M Hatori,K Ito,H Yamanaka, Jun. 2003, CANCER LETTERS, 195, 2, 177, 183
    DOI
  • A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese, K Suzuki,H Matsui,N Ohtake,S Nakata,T Takei,H Nakazato,H Okugi,H Koike,Y Ono,K Ito,K Kurokawa,H Yamanaka, Jul. 2003, JOURNAL OF BIOMEDICAL SCIENCE, 10, 4, 430, 435
    DOI
  • A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese, K Suzuki,H Matsui,N Ohtake,S Nakata,T Takei,H Nakazato,H Okugi,H Koike,Y Ono,K Ito,K Kurokawa,H Yamanaka, Jul. 2003, JOURNAL OF BIOMEDICAL SCIENCE, 10, 4, 430, 435
    DOI
  • Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population, K Suzuki,H Nakazato,H Matsui,H Koike,H Okugi,B Kashiwagi,M Nishii,N Ohtake,S Nakata,K Ito,H Yamanaka, Oct. 2003, CANCER, 98, 7, 1411, 1416
    DOI
  • Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population, K Suzuki,H Nakazato,H Matsui,H Koike,H Okugi,B Kashiwagi,M Nishii,N Ohtake,S Nakata,K Ito,H Yamanaka, Oct. 2003, CANCER, 98, 7, 1411, 1416
    DOI
  • Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate Cancer, Haruo Kato,Yosuke Furuya,Yoshiyuki Miyazawa,Takeshi Miyao,Takahiro Syuto,Masashi Nomura,Yoshitaka Sekine,Hidekazu Koike,Hiroshi Matsui,Yasuhiro Shibata,Kazuto Ito,Kazuhiro Suzuki, Nov. 2016, ANTICANCER RESEARCH, 36, 11, 6141, 6149
    DOI
  • Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate Cancer, Haruo Kato,Yosuke Furuya,Yoshiyuki Miyazawa,Takeshi Miyao,Takahiro Syuto,Masashi Nomura,Yoshitaka Sekine,Hidekazu Koike,Hiroshi Matsui,Yasuhiro Shibata,Kazuto Ito,Kazuhiro Suzuki, Nov. 2016, ANTICANCER RESEARCH, 36, 11, 6141, 6149
    DOI
  • Survivin Is Associated With Cell Proliferation and Has a Role in 1a,25-Dihydroxyvitamin D-3 Induced Cell Growth Inhibition in Prostate Cancer, Hidekazu Koike,Yasuyuki Morikawa,Yoshitaka Sekine,Hiroshi Matsui,Yasuhiro Shibata,Kazuhiro Suzuki, Apr. 2011, JOURNAL OF UROLOGY, 185, 4, 1497, 1503
    DOI
  • Survivin Is Associated With Cell Proliferation and Has a Role in 1a,25-Dihydroxyvitamin D-3 Induced Cell Growth Inhibition in Prostate Cancer, Hidekazu Koike,Yasuyuki Morikawa,Yoshitaka Sekine,Hiroshi Matsui,Yasuhiro Shibata,Kazuhiro Suzuki, Apr. 2011, JOURNAL OF UROLOGY, 185, 4, 1497, 1503
    DOI
  • YM155 reverses rapamycin resistance in renal cancer by decreasing survivin, Hidekazu Koike,Takashi Nitta,Yoshitaka Sekine,Seiji Arai,Yosuke Furuya,Masashi Nomura,Hiroshi Matsui,Yasuhiro Shibata,Kazuto Ito,Tetsunari Oyama,Kazuhiro Suzuki, Oct. 2014, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 140, 10, 1705, 1713
    DOI
  • YM155 reverses rapamycin resistance in renal cancer by decreasing survivin, Hidekazu Koike,Takashi Nitta,Yoshitaka Sekine,Seiji Arai,Yosuke Furuya,Masashi Nomura,Hiroshi Matsui,Yasuhiro Shibata,Kazuto Ito,Tetsunari Oyama,Kazuhiro Suzuki, Oct. 2014, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 140, 10, 1705, 1713
    DOI
  • Suicide attempt with an overdose of sunitinib, Seiji Arai,Hiroshi Matsui,Ryo Ohki,Yoshiyuki Miyazawa,Hidekazu Koike,Tadahiro Hashita,Yoshihiko Katsuyama,Yoshitaka Sekine,Masashi Nomura,Yasuhiro Shibata,Motoaki Hatori,Kazuto Ito,Koujirou Yamamoto,Shigeru Ohmori,Kazuhiro Suzuki, Oct. 2014, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 78, 4, 933, 935, Report scientific journal
    DOI
  • Suicide attempt with an overdose of sunitinib, Seiji Arai,Hiroshi Matsui,Ryo Ohki,Yoshiyuki Miyazawa,Hidekazu Koike,Tadahiro Hashita,Yoshihiko Katsuyama,Yoshitaka Sekine,Masashi Nomura,Yasuhiro Shibata,Motoaki Hatori,Kazuto Ito,Koujirou Yamamoto,Shigeru Ohmori,Kazuhiro Suzuki, Oct. 2014, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 78, 4, 933, 935, Report scientific journal
    DOI
  • Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content, Yasuhiro Shibata,Seiji Arai,Yoshiyuki Miyazawa,Takahiro Shuto,Masashi Nomura,Yoshitaka Sekine,Hidekazu Koike,Hiroshi Matsui,Kazuto Ito,Kazuhiro Suzuki, May 2017, PROSTATE, 77, 6, 672, 680
    DOI
  • Efficacy of Indocyanine Green Angiography on Microsurgical Subinguinal Varicocelectomy, Yasuhiro Shibata,Sota Kurihara,Seiji Arai,Haruo Kato,Tomomi Suzuki,Yoshiyuki Miyazawa,Hidekazu Koike,Kazuto Ito,Tetsuya Nakamura,Kazuhiro Suzuki, 2017, JOURNAL OF INVESTIGATIVE SURGERY, 30, 4, 247, 251
    DOI
  • Efficacy of Indocyanine Green Angiography on Microsurgical Subinguinal Varicocelectomy, Yasuhiro Shibata,Sota Kurihara,Seiji Arai,Haruo Kato,Tomomi Suzuki,Yoshiyuki Miyazawa,Hidekazu Koike,Kazuto Ito,Tetsuya Nakamura,Kazuhiro Suzuki, 2017, JOURNAL OF INVESTIGATIVE SURGERY, 30, 4, 247, 251
    DOI
  • A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients, Yoshiyuki Miyazawa,Yoshitaka Sekine,Takahiro Syuto,Masashi Nomura,Hidekazu Koike,Hiroshi Matsui,Yasuhiro Shibata,Kazuto Ito,Kazuhiro Suzuki, Aug. 2017, BMC UROLOGY, 17, 70
    DOI
  • Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL, Yuji Fujizuka,Kazuto Ito,Ryo Oki,Rie Suzuki,Yoshitaka Sekine,Hidekazu Koike,Hiroshi Matsui,Yasuhiro Shibata,Kazuhiro Suzuki, Aug. 2017, INTERNATIONAL JOURNAL OF UROLOGY, 24, 8, 602, 609
    DOI
  • Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL, Yuji Fujizuka,Kazuto Ito,Ryo Oki,Rie Suzuki,Yoshitaka Sekine,Hidekazu Koike,Hiroshi Matsui,Yasuhiro Shibata,Kazuhiro Suzuki, Aug. 2017, INTERNATIONAL JOURNAL OF UROLOGY, 24, 8, 602, 609
    DOI
  • Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells, Yoshiyuki Miyazawa,Yoshitaka Sekine,Haruo Kato,Yosuke Furuya,Hidekazu Koike,Kazuhiro Suzuki, Mar. 2017, PROSTATE, 77, 4, 337, 349
    DOI
  • Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells, Yoshiyuki Miyazawa,Yoshitaka Sekine,Haruo Kato,Yosuke Furuya,Hidekazu Koike,Kazuhiro Suzuki, Mar. 2017, PROSTATE, 77, 4, 337, 349
    DOI
  • Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab, Yoshiyuki Miyazawa,Yoshitaka Sekine,Takahiro Syuto,Masashi Nomura,Hidekazu Koike,Hiroshi Matsui,Yasuhiro Shibata,Kazuto Ito,Kazuhiro Suzuki, Jul. 2017, ANTICANCER RESEARCH, 37, 7, 3667, 3671
    DOI
  • YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin, Takashi Nitta,Hidekazu Koike,Takeshi Miyao,Yoshiyuki Miyazawa,Haruo Kato,Yosuke Furuya,Yoshitaka Sekine,Kazuhiro Suzuki, Jan. 2017, ANTICANCER RESEARCH, 37, 1, 75, 80
    DOI
  • YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin, Takashi Nitta,Hidekazu Koike,Takeshi Miyao,Yoshiyuki Miyazawa,Haruo Kato,Yosuke Furuya,Yoshitaka Sekine,Kazuhiro Suzuki, Jan. 2017, ANTICANCER RESEARCH, 37, 1, 75, 80
    DOI
  • Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer., Hideyasu Matsuyama,Tomoyuki Shimabukuro,Isao Hara,Yasuo Kohjimoto,Kazuhiro Suzuki,Hidekazu Koike,Hirotsugu Uemura,Taiji Hayashi,Munehisa Ueno,Kiichiro Kodaira,Yoshihiko Tomita,Toshihiko Sakurai,Nobuaki Shimizu, Oct. 2014, International journal of clinical oncology, 19, 5, 946, 54
    DOI
  • Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer., Hideyasu Matsuyama,Tomoyuki Shimabukuro,Isao Hara,Yasuo Kohjimoto,Kazuhiro Suzuki,Hidekazu Koike,Hirotsugu Uemura,Taiji Hayashi,Munehisa Ueno,Kiichiro Kodaira,Yoshihiko Tomita,Toshihiko Sakurai,Nobuaki Shimizu, Oct. 2014, International journal of clinical oncology, 19, 5, 946, 54
    DOI
  • Association of the genetic polymorphism of the CYP19 intron 4 [TTTA]n repeat with familial prostate cancer risk in a Japanese population., SUZUKI KAZUHIRO,NAKAZATO HARUKI,MATSUI HIROSI,KOIKE HIDEKAZU,OKUGI HIRONOBU,OHTAKE NOBUAKI,NAKATA SEIJI,HASUMI MASARU,YAMANAKA HIDETOSHI, 2003, Anticancer Research, 23,No.6D(4941-4946)
  • Placental growth factor gene expression in human prostate cancer and benign prostate hyperplasia, MATSUMOTO KAZUHISA,SUZUKI KAZUHIRO,KOIKE HIDEKAZU,HASUMI MASARU,MATSUI HIROSHI,OKUGI HIRONOBU,SHIBATA YASUHIRO,ITO KAZUTO,YAMANAKA HIDETOSHI, 2003, Anticancer Res, 23(5A):3767-3773
  • Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population., SUZUKI KAZUHIRO,FUKABORI YOSHITATSU,KUROKAWA KOHEI,YAMANAKA HIDETOSHI,MATSUI HIROSHI,OHTAKE NOBUAKI,NAKATA SEIJI,TAKEI TOMOYUKI,KOIKE HIDEKAZU,NAKAZATO HARUKI,OKUGI HIRONOBU,HASUMI MASARU, 2003, Int J Urol, 10,No.5(261-266)
    DOI
  • Cyclin D1 gene polymorphism and familial prostate cancer : The AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage., KOIKE HIDEKAZU,SUZUKI KAZUHIRO,YAMANAKA HIDETOSHI,TAKEI TOMOYUKI,NAKATA SEIJI,SATHO T,OHTAKE NOBUAKI, 2003, Anticancer Research, 23(6D):4947-4951
  • HER-2 gene polymorphism at codon 655 in familial prostate cancer in a Japanese population, Sekine Y,Hasumi M,Ohtake N,Nakata S,Nakazato H,Koike H,Suzuki K, 2005, Asia-Pacific Journal of Clinical Oncology, 1, 4, 133, 137
  • Methylation status of insulin-like growth factor-binding protein-3 promoter in prostate cancer tissues, Okugi H,Koike H,Sekine Y,Matsui H,Suzuki K, 2006, Asia-Pacific Journal of Clinical Oncology, 2, 3, 144, 149
    DOI
  • Remnant lipoproteins stimulate proliferation and activete MARK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cells, Sekine Y,Koike H,Nakano T,Nakajima K,Suzuki K, 2007, Clinica Chemica Acta, 383, 78, 84
    DOI
  • Gene expression profiles in human BPH: utilization of laser-capture microdissection and quantitative real-time PCR, SUZUKI KAZUHIRO,YAMANAKA HIDETOSHI,MATSUI HIROSHI,HASUMI MASARU,ONO YOSHIHIRO,NAKAZATO HARUKI,KOIKE HIDEKAZU,ITO KAZUTO,FUKABORI YOSHITATSU,KUROKAWA KOHEI, 2001, Anticancer Res, 21(6A): 3861-3864
  • Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population, SUZUKI KAZUHIRO,ITO KAZUTO,OHTAKE NOBUAKI,NAKATA SEIJI,TAKEI TOMOYUKI,MATSUI HIROSHI,ONO YOSHIHIRO,NAKAZATO HARUKI,HASUMI MASARU,KOIKE HIDEKAZU, 2002, Anticancer Res, 22(6B):3507-3511
  • Association of genetic polymorphisms of Glutathione-S-transpherase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population, NAKAZATO HARUKI,ITO KAZUTO,KUROKAWA KOHEI,YAMANAKA HIDETOSHI,SUZUKI KAZUHIRO,MATSUI HIROSHI,KOIKE HIDEKAZU,OKUGI HIRONOBU,OHTAKE NOBUAKI,TAKEI TOMOYUKI,NAKATA SEIJI,HASUMI MASARU, 2003, Anticancer Res, 23(3C):2897-2902
  • Luteinizing horomone (LH)-releasing hormone agonist reduces serum adrenal androgen levels in prostate cancer patients: Implications for the effect of LH on the adrenal glands., Nishii M,Nomura M,Sekine Y,Koike H,Matsui H,Shibata Y,Ito K,Oyama T,Suzuki K, 2012, J Androl., 33, 6, 1233, 1238
    DOI
  • Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related induces in men with total PSA in the 2.0-10.0ng/ml., Ito K,Miyakubo M,Sekine Y,Koike H,Matsui H,Shibata Y,Suzuki K, 2012, 31, 2, 305, 311
    DOI
  • Simple method for preventing inguinal hernias after radical retropubic prostatectomy, Koike\, Hidekazu,Matsui\, Hiroshi,Morikawa\, Yasuyuki,Shibata\, Yasuhiro,Ito\, Kazuto,Suzuki\, Kazuhiro, 2013, Prostate International, 1, 2, 76, 80
    DOI
  • Chlormadinone acetate is effective for hot flush during androgen deprivation therapy, Koike\, Hidekazu,Morikawa\, Yasuyuki,Matsui\, Hiroshi,Shibata\, Yasuhiro,Ito\, Kazuto,Suzuki\, Kazuhiro, 2013, Prostate International, 1, 3, 113, 116
    DOI
  • Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor, Kato\, Haruo,Sekine\, Yoshitaka,Furuya\, Yosuke,Miyazawa\, Yoshiyuki,Koike\, Hidekazu,Suzuki\, Kazuhiro, 2015, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 461, 1, 115, 121
    DOI
  • Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content, Shibata\, Yasuhiro,Arai\, Seiji,Miyazawa\, Yoshiyuki,Shuto\, Takahiro,Nomura\, Masashi,Sekine\, Yoshitaka,Koike\, Hidekazu,Matsui\, Hiroshi,Ito\, Kazuto,Suzuki\, Kazuhiro, 2017, PROSTATE, 77, 6, 672, 680
    DOI
  • Effect of Androgen-deprivation Therapy on Bone Mineral Density in Japanese Patients with Prostate Cancer, Miyazawa\, Yoshiyuki,Sekine\, Yoshitaka,Syuto\, Takahiro,Nomura\, Masashi,Koike\, Hidekazu,Matsui\, Hiroshi,Shibata\, Yasuhiro,Ito\, Kazuto,Suzuki\, Kazuhiro, 2018, IN VIVO, 32, 2, 409, 412
    DOI
  • Association of the genetic polymorphism of the CYP19 intron 4 [TTTA]n repeat with familial prostate cancer risk in a Japanese population., SUZUKI KAZUHIRO,NAKAZATO HARUKI,MATSUI HIROSI,KOIKE HIDEKAZU,OKUGI HIRONOBU,OHTAKE NOBUAKI,NAKATA SEIJI,HASUMI MASARU,YAMANAKA HIDETOSHI, 2003, 23,No.6D(4941-4946)
  • Placental growth factor gene expression in human prostate cancer and benign prostate hyperplasia, MATSUMOTO KAZUHISA,SUZUKI KAZUHIRO,KOIKE HIDEKAZU,HASUMI MASARU,MATSUI HIROSHI,OKUGI HIRONOBU,SHIBATA YASUHIRO,ITO KAZUTO,YAMANAKA HIDETOSHI, 2003, 23(5A):3767-3773
  • Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population., SUZUKI KAZUHIRO,FUKABORI YOSHITATSU,KUROKAWA KOHEI,YAMANAKA HIDETOSHI,MATSUI HIROSHI,OHTAKE NOBUAKI,NAKATA SEIJI,TAKEI TOMOYUKI,KOIKE HIDEKAZU,NAKAZATO HARUKI,OKUGI HIRONOBU,HASUMI MASARU, 2003, 10,No.5(261-266)
    DOI
  • 集合管癌(Bellini管癌)の一例, 小池 秀和,武井智幸,大竹伸明,真下正道,鈴木 和浩,山中 英寿, 2002, 52,No.4(267-270)
    DOI
  • Cyclin D1 gene polymorphism and familial prostate cancer : The AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage., KOIKE HIDEKAZU,SUZUKI KAZUHIRO,YAMANAKA HIDETOSHI,TAKEI TOMOYUKI,NAKATA SEIJI,SATHO T,OHTAKE NOBUAKI, 2003, 23(6D):4947-4951
  • 集合管癌（Bellini管癌）の一例, 小池 秀和, 2002, 52(4):267-270
    DOI
  • 浸潤性膀胱癌に対する動注放射線療法, 小池 秀和, 2003, 57(1):43-46
  • 維持血液透析を施行した血友病Ａの１例, 小池 秀和, 2004, 37(1):91-94
    DOI
  • 膀胱原発悪性リンパ腫の一例, 小池 秀和, 2004, 95(4):675-678
  • 検診における胸部Ｘ線像から発見された前立腺癌, 小池 秀和, 2004, 58(9):695-698
    DOI
  • HER-2 gene polymorphism at codon 655 in familial prostate cancer in a Japanese population, Sekine Y,Hasumi M,Ohtake N,Nakata S,Nakazato H,Koike H,Suzuki K, 2005, 1, 4, 133, 137
  • Methylation status of insulin-like growth factor-binding protein-3 promoter in prostate cancer tissues, Okugi H,Koike H,Sekine Y,Matsui H,Suzuki K, 2006, 2, 3, 144, 149
    DOI
  • Gene expression profiles in human BPH: utilization of laser-capture microdissection and quantitative real-time PCR, SUZUKI KAZUHIRO,YAMANAKA HIDETOSHI,MATSUI HIROSHI,HASUMI MASARU,ONO YOSHIHIRO,NAKAZATO HARUKI,KOIKE HIDEKAZU,ITO KAZUTO,FUKABORI YOSHITATSU,KUROKAWA KOHEI, 2001, 21(6A): 3861-3864
  • Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population, SUZUKI KAZUHIRO,ITO KAZUTO,OHTAKE NOBUAKI,NAKATA SEIJI,TAKEI TOMOYUKI,MATSUI HIROSHI,ONO YOSHIHIRO,NAKAZATO HARUKI,HASUMI MASARU,KOIKE HIDEKAZU, 2002, 22(6B):3507-3511
  • Association of genetic polymorphisms of Glutathione-S-transpherase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population, NAKAZATO HARUKI,ITO KAZUTO,KUROKAWA KOHEI,YAMANAKA HIDETOSHI,SUZUKI KAZUHIRO,MATSUI HIROSHI,KOIKE HIDEKAZU,OKUGI HIRONOBU,OHTAKE NOBUAKI,TAKEI TOMOYUKI,NAKATA SEIJI,HASUMI MASARU, 2003, 23(3C):2897-2902
  • 再燃抵抗性前立腺癌に対するドセタキセル療法の検討, 小池秀和,中里晴樹,新井誠二,森川泰如,関根芳岳,野村昌史,西井昌弘,曲 友弘,松井 博,山本 巧,柴田康博,羽鳥基明,伊藤一人,鈴木和浩, 2008, 21, 8, 1123, 1126
  • Growing teratoma syndromeの1例, 馬場 恭子,関根 芳岳,栗原 聰太,小池 秀和,松井 博,中里 晴樹,柴田 康博,伊藤 一人,鈴木 和浩,西井 昌弘,真下 透,岡村 桂吾,平戸 純子, 2016, 107, 2, 115, 120
    DOI
  • Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab, Miyazawa\, Yoshiyuki,Sekine\, Yoshitaka,Syuto\, Takahiro,Nomura\, Masashi,Koike\, Hidekazu,Matsui\, Hiroshi,Shibata\, Yasuhiro,Ito\, Kazuto,Suzuki\, Kazuhiro, 2017, 37, 7, 3667, 3671
    DOI
  • 去勢抵抗性前立腺癌に対するカバジタキセル療法の治療経験, 宮尾 武士,小池 秀和,栗原 聡太,中山 紘史,大木 亮,宮澤 慶行,周東 孝浩,関根 芳岳,野村 昌史,松井 博,柴田 康博,伊藤 一人,鈴木 和浩, 2017, 4, 2, 293, 297
  • 前立腺局所所見に乏しく急速に進行した転移性前立腺癌の1 例, 金山あずさ,宮尾武士,小池秀和,澤田達宏,馬場恭子,鈴木智美,栗原聰太,中山紘史,大木亮,宮澤慶行,藤塚雄司,周東孝浩,宮久保真意,野村昌史,関根芳岳,松井博,柴田康博,伊藤一人,鈴木和浩,平戸純子,猿木和久, 2018, 5, 1, 147, 150
  • Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related induces in men with total PSA in the 2.0-10.0ng/ml., Ito K,Miyakubo M,Sekine Y,Koike H,Matsui H,Shibata Y,Suzuki K, 2012, 31, 2, 305, 311
    DOI
  • Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range, Ito\, Kazuto,Miyakubo\, Mai,Sekine\, Yoshitaka,Koike\, Hidekazu,Matsui\, Hiroshi,Shibata\, Yasuhiro,Suzuki\, Kazuhiro, 2013, 31, 2, 305, 311
    DOI
  • Simple method for preventing inguinal hernias after radical retropubic prostatectomy, Koike\, Hidekazu,Matsui\, Hiroshi,Morikawa\, Yasuyuki,Shibata\, Yasuhiro,Ito\, Kazuto,Suzuki\, Kazuhiro, 2013, 1, 2, 76, 80
    DOI
  • Chlormadinone acetate is effective for hot flush during androgen deprivation therapy, Koike\, Hidekazu,Morikawa\, Yasuyuki,Matsui\, Hiroshi,Shibata\, Yasuhiro,Ito\, Kazuto,Suzuki\, Kazuhiro, 2013, 1, 3, 113, 116
    DOI
  • 精索静脈瘤に対する術中インドシアニングリーン蛍光血管造影下顕微鏡下低位結紮術の有用性：予備的検討, 柴田 康博,栗原 聰太,新井 誠二,宮澤 慶行,加藤 春雄,小池 秀和,伊藤 一人,中村 哲也,鈴木 和浩, 2015, 106, 4, 293, 298
    DOI
  • 総排泄腔外反症に有棘細胞癌を合併した一例, 大津 晃,宮尾 武士,小池 秀和,馬場 恭子,青木 雅典,栗原 聰太,宮澤 慶行,加藤 春雄,周東 孝浩,新井 誠二,古谷 洋介,新田 貴士,野村 昌史,関根 芳岳,松井 博,柴田 康博,伊藤 一人,鈴木 和浩,牧口 貴哉,森田 廣樹,古作 望,松本 和久,富田 光,山本 巧,林 雅道, 2015, 106, 4, 274, 279
    DOI
  • 家族性前立腺癌の遺伝子解析と臨床応用の可能性, 松井 博,大竹 伸明,中田 誠司,栗原 聰太,小池 秀和,鈴木 和浩, 2016, 3, 1, 53, 60
  • A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients, Miyazawa\, Yoshiyuki,Sekine\, Yoshitaka,Syuto\, Takahiro,Nomura\, Masashi,Koike\, Hidekazu,Matsui\, Hiroshi,Shibata\, Yasuhiro,Ito\, Kazuto,Suzuki\, Kazuhiro, 2017, 17, 70
    DOI
  • Effect of Androgen-deprivation Therapy on Bone Mineral Density in Japanese Patients with Prostate Cancer, Miyazawa\, Yoshiyuki,Sekine\, Yoshitaka,Syuto\, Takahiro,Nomura\, Masashi,Koike\, Hidekazu,Matsui\, Hiroshi,Shibata\, Yasuhiro,Ito\, Kazuto,Suzuki\, Kazuhiro, 2018, 32, 2, 409, 412
    DOI

Presentations

  • Survivin is associated with cell proliferation and plays a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer., 24th EAU annual meeting, 2009
  • Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer, 2008 AUA annual meeting, 2008
  • Farnesyl-diphosphate farnesyltransferase 1 is associated with the growth of renal cancer : association with anticancer effect of Statin, 24th EAU annual meeting, 2009
  • Farnesyl-diphosphate farnesyltransferase 1 is associated with the growth of renal cancer : association with anticancer effect of Statin, 2009 AUA annual meeting, 2009
  • Survivin is associated with cell proliferation and plays a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer., 2009 AUA annual meeting, 2009
  • Statin inhibits the proliferation of human prostate cancer cells via down-regulation of the survivin, 25th EAU annual meeting, 2010
  • Chlormadinone acetate is effective for hot flush in androgen deprivation therapy, 25th EAU annual meeting, 2010
  • Statin inhibits the proliferation of human renal cancer cells via down-regulation of the survivin through IGF-1 signaling, 2010
  • High-fat diet increased renal cancer growth, and the antitumor sensitization effect due to survivin inhibition in simvastatin treatment for renal cancer cells., AUA 106th annual Meeting, 2011
  • High-fat diet increases renal cancer growth accompanied by leptin increase, and survivin inhibition is effective for simvastatin resistant renal cancer., AUA 107th annual Meeting, 2012
  • Simple method of preventing postradical retropubic prostatectomy inguinal hernia., 27th Annual EAU Congress, 2012
  • Survivin is associated with cell proliferation and plays a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer., 24th EAU annual meeting, 2009
  • Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer, 2008 AUA annual meeting, 2008
  • Farnesyl-diphosphate farnesyltransferase 1 is associated with the growth of renal cancer : association with anticancer effect of Statin, 24th EAU annual meeting, 2009
  • Farnesyl-diphosphate farnesyltransferase 1 is associated with the growth of renal cancer : association with anticancer effect of Statin, 2009 AUA annual meeting, 2009
  • Survivin is associated with cell proliferation and plays a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer., 2009 AUA annual meeting, 2009
  • Statin inhibits the proliferation of human prostate cancer cells via down-regulation of the survivin, 25th EAU annual meeting, 2010
  • Chlormadinone acetate is effective for hot flush in androgen deprivation therapy, 25th EAU annual meeting, 2010
  • Statin inhibits the proliferation of human renal cancer cells via down-regulation of the survivin through IGF-1 signaling, 2010
  • High-fat diet increased renal cancer growth, and the antitumor sensitization effect due to survivin inhibition in simvastatin treatment for renal cancer cells., AUA 106th annual Meeting, 2011
  • High-fat diet increases renal cancer growth accompanied by leptin increase, and survivin inhibition is effective for simvastatin resistant renal cancer., AUA 107th annual Meeting, 2012
  • Simple method of preventing postradical retropubic prostatectomy inguinal hernia., 27th Annual EAU Congress, 2012

Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.